RCOM arm to ink infra sharing deal with Swan Telecom for 15 yrs

ADAG  controlled Reliance Communications’ (RCOM) hived off tower arm Reliance Telecom Infrastructure (RTIL) is expected to finalize infrastructure-sharing deal with Swan Telecom for fifteen years in a month. It is widely speculated that Swan Telecom once upon a time belonged to Reliance ADAG Group before being transfered to Balwas Group of Mumbai. Etisalat has now … Read more RCOM arm to ink infra sharing deal with Swan Telecom for 15 yrs

Nano shifts to forward gear – Bookings Open Last Week

The Tata Group’s flagship automobile major Tata Motors is expected to flag off  bookings for its small car – Nano – by the end of the month while deliveries will begin next month. The first batch of Nanos will be from the company’s Pantnagar facility. Despite the slowdown in the global auto sector that has … Read more Nano shifts to forward gear – Bookings Open Last Week

Layoffs in Indian Export Sector – Collateral Damage

Until recently, due to its large working population, India was touted as one among few countries that enjoyed a ‘demographic dividend’. But with one of the fallouts of the global crisis being job losses, this could become a demographic nightmare. With most of the ‘officially reported’ 500,000 job losses during the last quarter exports related, … Read more Layoffs in Indian Export Sector – Collateral Damage

FII net sellers of Rs 363 cr in cash segment on Thursday

Foreign institutional investors (FIIs) were net sellers of Rs 363.48 crore (provisional) in the cash segment on Thursday, according to data available on the BSE website. While FIIs made gross purchases of Rs 809.57 crore, their gross sales stood at Rs 1,173.05 crore. Domestic institutional investors (DIIs) were net buyers of Rs 108.44 crore (provisional) … Read more FII net sellers of Rs 363 cr in cash segment on Thursday

Pharma cos to face tougher regime on price controls

The National Pharmaceutical Pricing Authority (NPPA) is taking a tougher stand against arbitrary price increases by the pharmaceutical companies. The pricing regulator has said that drug makers will not be allowed to raise prices of existing drugs by changing the composition. NPPA has said that if the drug companies introduce a new drug by changing … Read more Pharma cos to face tougher regime on price controls